Canada High Court Upholds Plavix 'Selection' Patent
In a landmark ruling that could have major implications for generic-drug makers in Canada, the Supreme Court of Canada has held that a selection patent for a key ingredient in the...To view the full article, register now.
Already a subscriber? Click here to view full article